help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published ahead of print on January 17, 2008, doi:10.1164/rccm.200709-1413OC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online Supplement
Right arrow All Versions of this Article:
200709-1413OCv1
177/8/853    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, T. F.
Right arrow Articles by Sethi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, T. F.
Right arrow Articles by Sethi, S.
American Journal of Respiratory and Critical Care Medicine Vol 177. pp. 853-860, (2008)
© 2008 American Thoracic Society
doi: 10.1164/rccm.200709-1413OC


Original Article

Pseudomonas aeruginosa in Chronic Obstructive Pulmonary Disease

Timothy F. Murphy1,2,3, Aimee L. Brauer1, Karen Eschberger1,3, Phyllis Lobbins1,3, Lori Grove1, Xueya Cai4 and Sanjay Sethi1,3

1 Department of Medicine and 2 Department of Microbiology and Immunology, State University of New York at Buffalo, Buffalo New York; 3 Veterans Affairs Western New York Healthcare System, Buffalo, New York; and 4 Department of Biostatistics, State University of New York at Buffalo, Buffalo, New York

Correspondence and requests for reprints should be addressed to Timothy F. Murphy, M.D., Medical Research 151, Buffalo Veterans Affairs Medical Center, 3495 Bailey Avenue, Buffalo, NY 14215. E-mail: murphyt{at}buffalo.edu

Rationale: Pseudomonas aeruginosa is isolated from adults with chronic obstructive pulmonary disease (COPD) in cross-sectional studies. However, patterns of carriage and the role of P. aeruginosa in COPD are unknown.

Objectives: To elucidate carriage patterns, phenotypes of strains, clinical manifestations, and the antibody response to P. aeruginosa in COPD.

Methods: A prospective study of adults with COPD was conducted. Isolates of P. aeruginosa were subjected to genotypic and phenotypic analysis. Sputum samples were studied for P. aeruginosa DNA, and immune responses were assayed.

Measurements and Main Results: We analyzed longitudinal clinical data, sputum cultures, pulsed-field gel electrophoresis of bacterial DNA, polymerase chain reaction of sputum, and immunoblot assays of serum. Fifty-seven episodes of acquisition of strains of P. aeruginosa were observed in 39 of 126 patients over 10 years. Acquisition of a new strain was associated with exacerbation. Thirty-one episodes of carriage were followed by clearance of the strain; 16 were of short (<1 mo) duration. Thirteen strains demonstrated persistence, and 13 strains were of indeterminate duration. Six strains were mucoid and were more likely to persist than nonmucoid strains (P = 0.005). Antibody responses developed in 53.8% of persistent carriage and in only 9.7% of short-term carriage episodes (P = 0.003). Antibiotics did not account for clearance.

Conclusions: Two distinct patterns of carriage by P. aeruginosa were observed: (1) short-term colonization followed by clearance and (2) long-term persistence. Mucoid strains showed persistence. Acquisition of P. aeruginosa is associated with the occurrence of an exacerbation. Serum antibody responses do not mediate clearance of P. aeruginosa.

Key Words: respiratory tract infection • exacerbation • immune response • sputum • polymerase chain reaction


AT A GLANCE COMMENTARY

Scientific Knowledge on the Subject
Pseudomonas aeruginosa is isolated from the sputum in chronic obstructive pulmonary disease, but carriage patterns, clinical manifestations, and immune responses have not been studied prospectively.

What This Study Adds to the Field
This study shows that (1) there are distinct patterns of carriage of P. aeruginosa in chronic obstructive pulmonary disease, (2) mucoid strains are uncommon but persistent, (3) acquisition of a new strain is associated with exacerbation, and (4) antibody responses are a marker for colonization.

 



This article has been cited by other articles:


Home page
Eur Respir JHome page
C. Garcia-Vidal, P. Almagro, V. Romani, M. Rodriguez-Carballeira, E. Cuchi, L. Canales, D. Blasco, J. L. Heredia, and J. Garau
Pseudomonas aeruginosa in patients hospitalised for COPD exacerbation: a prospective study
Eur. Respir. J., November 1, 2009; 34(5): 1072 - 1078.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M. Miravitlles, A. Marin, E. Monso, S. Vila, C. de la Roza, R. Hervas, C. Esquinas, M. Garcia, L. Millares, J. Morera, et al.
Efficacy of moxifloxacin in the treatment of bronchial colonisation in COPD
Eur. Respir. J., November 1, 2009; 34(5): 1066 - 1071.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
M. Sabet, C. E. Miller, T. G. Nolan, K. Senekeo-Effenberger, M. N. Dudley, and D. C. Griffith
Efficacy of Aerosol MP-376, a Levofloxacin Inhalation Solution, in Models of Mouse Lung Infection Due to Pseudomonas aeruginosa
Antimicrob. Agents Chemother., September 1, 2009; 53(9): 3923 - 3928.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
G. G. Brusselle, T. Demoor, K. R. Bracke, C-A. Brandsma, and W. Timens
Lymphoid follicles in (very) severe COPD: beneficial or harmful?
Eur. Respir. J., July 1, 2009; 34(1): 219 - 230.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
S. Sethi and T. F. Murphy
Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., November 27, 2008; 359(22): 2355 - 2365.
[Full Text] [PDF]


Home page
J. Immunol.Home page
S. C. Wesselkamper, B. L. Eppert, G. T. Motz, G. W. Lau, D. J. Hassett, and M. T. Borchers
NKG2D Is Critical for NK Cell Activation in Host Defense against Pseudomonas aeruginosa Respiratory Infection
J. Immunol., October 15, 2008; 181(8): 5481 - 5489.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2008 American Thoracic Society
  CCM abstracts